Rocket Lab (NASDAQ:RKLB) Stock Falls 3.8% on Insider Selling

Rocket Lab Corporation (NASDAQ:RKLB) shares traded down 3.8% during trading on Wednesday following insider selling activity. The company traded as low as $50.41 and last traded at $52.37. 18,642,381 shares traded hands during trading, a decline of 18% from the average daily volume of 22,653,801 shares. The stock had previously closed at $54.43.

Specifically, CFO Adam Spice sold 140,157 shares of the firm’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $52.79, for a total transaction of $7,398,888.03. Following the transaction, the chief financial officer directly owned 1,155,967 shares in the company, valued at $61,023,497.93. This trade represents a 10.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Nina Armagno sold 10,926 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $52.78, for a total value of $576,674.28. Following the completion of the sale, the director owned 100,496 shares of the company’s stock, valued at $5,304,178.88. The trade was a 9.81% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on RKLB shares. Needham & Company LLC reaffirmed a “buy” rating and issued a $120.00 target price on shares of Rocket Lab in a research note on Friday, October 16th. Morgan Stanley reaffirmed an “overweight” rating on shares of Rocket Lab in a research note on Wednesday, July 8th. Berenberg Bank initiated coverage on shares of Rocket Lab in a report on Wednesday, September 2nd. They set a “buy” rating and a $83.00 target price for the company. Citigroup reissued a “market outperform” rating on shares of Rocket Lab in a research note on Friday, October 16th. Finally, Roth Capital restated a “buy” rating on shares of Rocket Lab in a report on Thursday, October 15th. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $102.05.

Key Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab completed its 99th Electron mission, successfully deploying an Earth-imaging satellite for Japan’s iQPS. The milestone reinforces Electron’s launch reliability and established operating record. Rocket Lab launches 99th Electron mission
• Positive Sentiment: Rocket Lab’s Space Systems business and the Iridium agreement are highlighted as potential growth drivers, while NASA’s move toward commercial space stations could create additional launch demand. These opportunities support the longer-term case, though some depend on future execution. Space Systems and Iridium deal growth outlook Rocket Lab as a launch option for commercial stations
• Neutral Sentiment: Rocket Lab is scheduled to report Q3 results after the market closes Nov. 9. Analysts expect revenue of about $257 million and a loss of roughly $0.07 per share; revenue growth could be encouraging, but investors will also watch margins and cash use. Expectations ahead of Q3 earnings
• Negative Sentiment: Neutron remains unflown, and its delayed debut raises execution risk around a key potential growth catalyst. Premium valuation, cash burn and margin pressure may amplify the market’s reaction to earnings or schedule changes. Neutron and Rocket Lab’s growth outlook
• Negative Sentiment: The CFO and a director recently sold shares under pre-arranged Rule 10b5-1 plans. Such planned sales do not necessarily signal a change in their outlook, but may add to investor caution ahead of earnings. Director share sale
• Negative Sentiment: Globalstar has raised concerns that Rocket Lab’s supplier relationship could create incentives to favor Iridium, presenting potential commercial or regulatory friction for the deal. Globalstar concerns about the Iridium deal

Rocket Lab Price Performance

The stock has a market cap of $31.34 billion, a P/E ratio of -193.96 and a beta of 3.15. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The firm has a 50-day moving average price of $63.54 and a 200-day moving average price of $79.57.

Rocket Lab (NASDAQ:RKLB) last released its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). The firm had revenue of $234.07 million for the quarter, compared to the consensus estimate of $231.62 million. Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. On average, analysts forecast that Rocket Lab Corporation will post -0.20 earnings per share for the current fiscal year.

Institutional Trading of Rocket Lab

A number of hedge funds have recently modified their holdings of RKLB. Versant Capital Management Inc boosted its stake in shares of Rocket Lab by 5.1% during the 2nd quarter. Versant Capital Management Inc now owns 2,049 shares of the rocket manufacturer’s stock worth $208,000 after purchasing an additional 100 shares during the period. Bartlett & CO. Wealth Management LLC raised its position in Rocket Lab by 7.1% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 1,869 shares of the rocket manufacturer’s stock worth $120,000 after purchasing an additional 124 shares during the period. Parvin Asset Management LLC raised its position in Rocket Lab by 4.0% in the 1st quarter. Parvin Asset Management LLC now owns 3,665 shares of the rocket manufacturer’s stock worth $235,000 after purchasing an additional 140 shares during the period. Wedmont Private Capital grew its stake in shares of Rocket Lab by 3.5% during the third quarter. Wedmont Private Capital now owns 4,644 shares of the rocket manufacturer’s stock valued at $318,000 after buying an additional 157 shares during the last quarter. Finally, DMC Group LLC boosted its holdings in Rocket Lab by 5.0% during the 2nd quarter. DMC Group LLC now owns 3,553 shares of the rocket manufacturer’s stock valued at $361,000 after acquiring an additional 170 shares during the period. Institutional investors own 71.78% of the company’s stock.

About Rocket Lab

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.